» Articles » PMID: 34511208

Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure: How to Select the Right Candidate?

Overview
Journal Heart Fail Clin
Date 2021 Sep 13
PMID 34511208
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac resynchronization therapy is a well-established treatment of heart failure with reduced left ventricular ejection fraction and a wide QRS complex. Cardiac contractility modulation therapy is an emerging electrical treatment indicated for use in patients with symptomatic heart failure caused by moderate-to-severe systolic left ventricular dysfunction (left ventricular ejection fraction ranging from 25% to 45%), with no indication for cardiac resynchronization therapy. Cardiac contractility modulation therapy improves functional status, exercise capacity, quality of life, and possibly prevents hospital admissions in indicated patients. An algorithm for patient selection for these two forms of electrical therapy for heart failure is presented.

Citing Articles

Device-therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapy.

Yuecel G, Gaasch L, Kodeih A, Hetjens S, Yazdani B, Pfleger S ESC Heart Fail. 2024; 12(1):456-466.

PMID: 39344273 PMC: 11769612. DOI: 10.1002/ehf2.15067.


Novel Medical Treatments and Devices for the Management of Heart Failure with Reduced Ejection Fraction.

Alfieri M, Bruscoli F, Di Vito L, Di Giusto F, Scalone G, Marchese P J Cardiovasc Dev Dis. 2024; 11(4).

PMID: 38667743 PMC: 11050600. DOI: 10.3390/jcdd11040125.


Enhancing myocardial function with cardiac contractility modulation: potential and challenges.

Li Z, Liu Q, Zhou S, Xiao Y ESC Heart Fail. 2023; 11(1):1-12.

PMID: 37947013 PMC: 10804199. DOI: 10.1002/ehf2.14575.


Use of Cardiac Contractility Modulation as Bridge to Transplant in an Obese Patient With Advanced Heart Failure: A Case Report.

Masarone D, Petraio A, Fiorentino A, Dellegrottaglie S, Valente F, Ammendola E Front Cardiovasc Med. 2022; 9:833143.

PMID: 35252403 PMC: 8889036. DOI: 10.3389/fcvm.2022.833143.